Randomized, double-blind, phase III trial of a personalized peptide vaccination for human leukocyte antigen-A24-positive glioblastoma multiforme patients refractory …
M Terasaki, Y Narita, Y Arakawa, K Sugiyama, T Aoki… - 2017 - ascopubs.org
2000 Background: To establish whether personalized peptide vaccination (PPV) is clinically
beneficial for human leukocyte antigen (HLA)-A24-positive glioblastoma multiforme (GBM)
patients refractory to temozolomide (TMZ)-based therapy. Methods: From January 2012 to …
beneficial for human leukocyte antigen (HLA)-A24-positive glioblastoma multiforme (GBM)
patients refractory to temozolomide (TMZ)-based therapy. Methods: From January 2012 to …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com

没有评论:
发表评论